Results 161 to 170 of about 617,017 (357)
Correction: Case Report: Contrast adenosine stress echocardiography revealing microvascular dysfunction in cardiac AL amyloidosis. [PDF]
Dai Y +5 more
europepmc +1 more source
This work introduces an open‐source all‐optical platform for functional phenotyping of human stem cell‐derived neurons. The system integrates optogenetics, calcium imaging, automated acquisition, and analysis to resolve single‐cell and network activity, enabling longitudinal measurements, disease modeling, and pharmacological screening in preclinical ...
Wardiya Afshar‐Saber +12 more
wiley +1 more source
<i>In Vitro</i> Evolution of the Adenosine A<sub>2A</sub> Receptor Based on an Antagonist Binding Using a Ribosome Display. [PDF]
Fukasawa G +12 more
europepmc +1 more source
Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy
P. Beavis +17 more
semanticscholar +1 more source
ETV4 coordinates a dual transcriptional program by upregulating MET and asparagine synthetase (ASNS). The resulting asparagine (Asn) secretion acts as a metabolic signal, reprogramming hepatic stellate cells (HSCs) and primary cancer‐associated fibroblasts (CAFs) toward an inflammatory phenotype. These activated stromal cells release HGF to sustain the
Dujiang Fu +14 more
wiley +1 more source
Remote control of movement disorders using a photoactive adenosine A2A receptor antagonist
Jaume Taura +8 more
openalex +2 more sources
Impaired adenosine pathways in HFpEF: insights into cardiorenal alterations and endothelial responses. [PDF]
Riemma MA +16 more
europepmc +1 more source
Deep Learning‐Powered Scalable Cancer Organ Chip for Cancer Precision Medicine
This scalable, low‐cost Organ Chip platform, made via injection molding, uses capillary pinning for hydrogel confinement and supports versatile tissue coculture and robust imaging. Deep learning enables label‐free, sensitive phenotypic analysis.
Yu‐Chieh Yuan +24 more
wiley +1 more source
A2AR as a key target for immune microenvironment remodeling in prostate cancer. [PDF]
Yan L, Yang Z, Zhao X, Chen Y, Wang Z.
europepmc +1 more source

